Skip to content

Prof. Ofer Merimsky

Oncologist, Deputy Director of the Oncology Center, Head of Bone and Soft Tissue Oncology Unit

Languages
  • עברית
  • Eng
Message on WhatsApp

We respond within 30 minutes

No reviews yet

About the Doctor

Professor Ofer Merimsky is one of Israel’s leading oncologists with extensive clinical experience in managing complex oncological conditions, including bone and soft tissue sarcomas, spinal tumors, and rare cancers.

Professor Merimsky specializes in non-surgical oncology and actively uses modern systemic therapies, radiation therapy, and combined treatment approaches. He is also involved in developing new treatment strategies for sarcomas and other rare tumors.

Alongside his clinical work, Professor Merimsky is actively engaged in research and academic activity.

Areas of expertise

  • Bone and soft tissue sarcomas
  • Spine tumors
  • Brain tumors
  • Lung and thoracic cancers
  • Breast cancer
  • Uterine cancer
  • Prostate cancer
  • Kidney cancer
  • Neuroendocrine tumors
  • Gastrointestinal stromal tumors (GIST)

Professional Experience

  • Deputy Director of the Oncology Center
  • Head of Bone and Soft Tissue Oncology Unit
  • Director of Oncology Follow-Up Clinic
  • Professor Tel Aviv University

Education

  • Hebrew University of Jerusalem, Israel Faculty of Medicine

Training

  • Residency in Oncology and Radiation Therapy Israel
  • Fellowship in Oncology and Brachytherapy New York, USA
  • Fellowship in Bone and Soft Tissue Sarcoma Treatment Gustave Roussy Institute, Paris, France

Research

  • New treatment strategies for sarcomas and other rare tumors He is also involved in developing new treatment strategies for sarcomas and other rare tumors.

Publications

Associations

  • Israeli Society of Clinical Oncology and Radiation Therapy (ISCORT)
  • Connective Tissue Oncology Society (CTOS)
  • European Society for Medical Oncology (ESMO)
  • American Society of Clinical Oncology (ASCO)
  • International Association for the Study of Lung Cancer (IASLC)

Book a Consultation

Clinic services are provided privately and via agreements with HMOs and insurers. The TAMC team is available for any request and committed to top-level care.

Frequently Asked Questions

When do patients usually come for a second opinion?

Most of the time — after they already received a diagnosis.
Some patients just want confirmation. Others feel uncertain. And sometimes they simply want someone to explain everything again, in a calmer way.
I don’t think second opinions are unusual. In oncology, it’s actually quite common. Different specialists may suggest different approaches, and that’s normal.
If someone feels unsure, I usually encourage them to ask questions and take time before making decisions.

Why is it important to see a specialist for sarcoma?

Sarcomas are not something we see every day.
Because of that, patients often arrive confused. They’ve spoken to several doctors, read information online, and still feel uncertain about the next step.
These tumors can behave differently from other cancers. Treatment decisions are often more complex, and experience becomes important.
Sometimes just reviewing imaging and pathology again can change the overall plan.

Are tumors of the spine always dangerous?

Not necessarily.
Some spinal tumors grow slowly and may be monitored. Others require more active treatment. It really depends on the situation.
Patients often assume the worst. That’s understandable. But in practice, every case is different.
The first step is always to understand exactly what we are dealing with.

Is surgery always required for lung cancer?

No, not always.
Treatment options today are very different from what they were years ago. We now have targeted therapies and immunotherapy, which sometimes allow us to avoid surgery.
Of course, surgery is still important in many cases. But not in all of them.
This is why treatment decisions are usually made individually.

What if treatment didn’t work or the disease returned?

This is one of the hardest situations for patients.
But recurrence doesn’t mean the end of treatment options. Medicine continues to move forward. Sometimes new therapies become available.
I often tell patients — we need to review everything again. Sometimes we still find additional possibilities.

Why do oncologists discuss cases together?

Because cancer care is rarely simple.
We often review cases with radiologists, surgeons, and other specialists. Everyone looks at the situation from a slightly different perspective.
This helps us make more balanced decisions.

Is there hope in complex cases?

Patients ask this question often.
And honestly, many complicated cases still have options. Treatment continues to evolve, and new approaches appear.
The most important thing is not to rush. Careful evaluation often helps us find a reasonable path forward.

Patient Reviews (0)

No reviews yet

Videos with the Doctor